|
Characteristic
|
RAE (n = 24)
|
Non-RAE (n = 30)
|
p value
|
|---|
|
Age (years)
|
59.0 ± 11.8
|
59.3 ± 8.9
|
0.9
|
|
Sex (n)
| | |
0.15
|
|
Male
|
15 (62.5%)
|
24 (80%)
| |
|
Female
|
9 (37.5%)
|
6 (20%)
| |
|
BMI kg/m2
|
23.1 ± 2.8
|
23.4 ± 3.3
|
0.74
|
|
Affected kidney (n)
| |
0.76
|
|
Right
|
13 (54.2%)
|
15 (50%)
| |
|
Left
|
11 (44.8%)
|
15 (50%)
| |
|
Tumor size (cm)
|
11.1 ± 3.5
|
7.9 ± 2.7
|
0.001*
|
|
Clinical T stage (n)
| |
0.91
|
|
T3a
|
9 (37.5%)
|
10 (33.3%)
| |
|
T3b
|
13 (54.2%)
|
18 (60%)
| |
|
T3c
|
2 (8.3%)
|
2 (6.7%)
| |
|
Thrombus level (Mayo)
| |
0.83
|
|
0
|
6 (25%)
|
8 (26.7%)
| |
|
I
|
9 (37.5)
|
7 (23.3%)
| |
|
II
|
6 (25%)
|
9 (30%)
| |
|
III
|
2 (8.3%)
|
4 (13.3%)
| |
|
IV
|
1 (4.2%)
|
2 (6.7%)
| |
|
NYHA classification
| |
0.56
|
|
I
|
16 (66.7%)
|
16 (53.3%)
| |
|
II
|
7 (29.1%)
|
13 (43.3%)
| |
|
III
|
1 (4.2%)
|
1 (3.4%)
| |
|
ASA score
| | |
0.81
|
|
I
|
1 (4.2%)
|
1 (3.4%)
| |
|
II
|
8 (33.3%)
|
14 (46.6%)
| |
|
III
|
14 (58.3%)
|
14 (46.6%)
| |
|
IV
|
1 (4.2%)
|
1 (3.4%)
| |
- I-RAE instant renal artery embolization, BMI body mass index
- *p < 0.05
